StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Non-major products combined by Quarter

Non-major products combined — Outside U.S. revenue ($M) [Q1–Q3 10-Q & FY 10-K] ($M)

QuarterlyAnnual

Eli Lilly Non-major products combined: $1,481M in Q2 2026, down 35.2% from a year earlier.

Latest, Q2 2026
1,481
Period ended Jun 30, 2026
Change on a year earlier
-35.2%
2,285 in Q2 2025
History
34 quarters
Since Q1 2018
Sources
34
Documents cited below

Where the Q2 2026 figure comes from

“|| Other | 1,842 | 1,481 | 3,322 | 2,859 | 16”

Source: Form 10-Q FY2026Q2 (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K MD&A.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-major products combined — Outside U.S. revenue ($M) [Q1–Q3 10-Q & FY 10-K] ($M)Year on yearSource
Q2 2026Jun 30, 20261,481-35.2%Form 10-Q FY2026Q2 (filed 2026-08-05) ↗
Q1 2026Mar 31, 20261,393-45.3%Form 10-Q FY2026Q1 (filed 2026-04-30) ↗
Q4 2025Dec 31, 20252,510+140.3%Form 10-K FY2025 (filed 2026-02-12) ↗
Q3 2025Sep 30, 20252,726+663.9%Form 10-Q FY2025Q3 (filed 2025-10-30) ↗
Q2 2025Jun 30, 20252,285+527.4%Form 10-Q FY2025Q2 (filed 2025-08-07) ↗
Q1 2025Mar 31, 20252,545+534.0%Form 10-Q FY2025Q1 (filed 2025-05-01) ↗
Q4 2024Dec 31, 20241,044+110.7%Form 10-K FY2024 (filed 2025-02-19) ↗
Q3 2024Sep 30, 2024357-13.7%Form 10-Q FY2024Q3 (filed 2024-10-30) ↗
Q2 2024Jun 30, 2024364-26.0%Form 10-Q FY2024Q2 (filed 2024-08-08) ↗
Q1 2024Mar 31, 2024402-6.9%Form 10-Q FY2024Q1 (filed 2024-04-30) ↗
Q4 2023Dec 31, 2023496+113.7%Form 10-K FY2023 (filed 2024-02-21) ↗
Q3 2023Sep 30, 2023413+71.9%Form 10-Q FY2023Q3 (filed 2023-11-02) ↗
Q2 2023Jun 30, 2023492+94.4%Form 10-Q FY2023Q2 (filed 2023-08-08) ↗
Q1 2023Mar 31, 2023431+70.8%Form 10-Q FY2023Q1 (filed 2023-04-27) ↗
Q4 2022Dec 31, 2022232-1,054.3%Form 10-K FY2022 (filed 2023-02-22) ↗
Q3 2022Sep 30, 2022241-16.0%Form 10-Q FY2022Q3 (filed 2022-11-01) ↗

Cite this data

StockData. (2026). Eli Lilly Non-major products combined ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-other-products-nonus

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.